Surviving Mesothelioma / Chemotherapy
Chemotherapy
What is Chemotherapy?
Chemotherapy is a group of toxic drugs that kill cells (mesothelioma, other cancers, and healthy cells) by damaging their DNA. Chemotherapy is a cytotoxic therapy, meaning it kills cells. Chemo drugs target rapidly growing cancer cells, but they can also affect healthy cells that grow rapidly such as blood cells. The effect of these drugs on both cancer and normal cells often causes chemo side effects.
Alimta (Pemetrexed) and Cisplatin
As of this writing, the only FDA approved chemotherapy for mesothelioma is a combination of Alimta (pemetrexed) and cisplatin. In February 2004, the Food and Drug Administration approved pemetrexed for the treatment of malignant pleural mesothelioma in combination with cisplatin for patients whose disease is either inoperable or who are not otherwise candidates for curative surgery. Patients who take this chemo regimen are often prescribed folic acid and vitamin B12 supplement to help reduce side effects from the chemotherpay. Patients are usually prescribed corticosteroids to reduce the risk of skin rashes as well.
The recommended dose of pemetrexed is 500 mg/m administered as an intravenous infusion over 10 minutes on day 1 of each 21-day cycle together with cisplatin at a dose of 75 mg/m infused over 2 hours beginning 30 minutes after the pemetrexed infusion.
The Clinical Trial that Approved Alimta (Pemetrexed) and Cisplatin
There was one key clinical trial that led to the FDA approval of this regimen for mesothelioma. Two hundred twenty-six pleural mesothelioma patients were randomized to receive pemetrexed and cisplatin, while 222 patients were randomized to receive cisplatin alone. The primary study end point was survival. Median survival times were 12.1 months for the pemetrexed plus cisplatin treatment group and 9.3 months for the cisplatin alone group.
Median time to progression (regrowth of tumor) was longer in the pemetrexed/cisplatin arm of the study, 5.7 months versus 3.9 months. This means that the mesothelioma patients who received both drugs had their tumors return a median of 1.8 months longer versus those who only got one drug.
Like most chemo drugs, pemetrexed kills blood cells so the most common adverse events were neutropenia, fatigue, leukopenia, nausea, dyspnea, and vomiting.
On February 4, 2004, pemetrexed was approved by the FDA in combination with cisplatin for the treatment of patients with malignant pleural mesothelioma whose disease is inoperable or who are otherwise not candidates for curative surgery.
Related Posts
Extending Mesothelioma Survival with Chemotherapy - In the continued quest to improve the effectiveness of chemotherapy treatment for malignant pleural mesothelioma, two new studies have been published this week on the effectiveness of adding additional drugs to the standard combination. The majority of patients who receive a mesothelioma diagnosis will have treatment that includes chemotherapy. According to data from the National Cancer Institute’s SEER database, the chemotherapy regimen prescribed most often … Continue reading Extending Mesothelioma Survival with Chemotherapy 
New Immunotherapy Drug Stops Mesothelioma in Half of Patients Tested - The results are in on the Phase I/II trial of the mesothelioma drug ONCOS-102 and researchers say there is reason to be excited. As Surviving Mesothelioma first reported in the fall of 2016, ONCOS-102 and standard chemotherapy significantly slowed the growth of malignant mesothelioma tumors in preclinical studies of infected mice. Now, the first human trial suggests that it can do the same thing in … Continue reading New Immunotherapy Drug Stops Mesothelioma in Half of Patients Tested 
“Spray On” Drugs May Be New Option for Peritoneal Mesothelioma Patients - A new, minimally-invasive way of delivering drugs right to the site of a tumor is being called “safe and feasible” for people with recurrent malignant mesothelioma. Right now, mesothelioma patients whose cancer comes back after surgery and systemic chemotherapy have few viable treatment options. The new procedure, called Pressurized Inraperitoneal Aerosol Chemotherapy (PIPAC), may change that. During PIPAC, chemotherapy drugs are essentially “sprayed” as gas … Continue reading “Spray On” Drugs May Be New Option for Peritoneal Mesothelioma Patients 
Study Finds Chemotherapy Unlikely to Improve Peritoneal Mesothelioma Survival - A new study from the University of Illinois suggests that patients with peritoneal mesothelioma who undergo surgery may not get any benefit from having chemotherapy, too. Mesothelioma patients who have cytoreductive surgery, which is also called debulking surgery, tend to live more than four times as long as those who do not have the surgery. Rinsing the abdominal cavity with a heated solution of cancer-killing … Continue reading Study Finds Chemotherapy Unlikely to Improve Peritoneal Mesothelioma Survival 
Home-Based Rehab Helps Mesothelioma Patients Bounce Back After Chemotherapy - New evidence suggests that a pulmonary rehabilitation program that comes to them might help patients recover after pleural mesothelioma treatment. Experts in pulmonary cancers at several French institutions recently published what they called a “real-life feasibility study” of home-based rehab in patients who had received chemotherapy for either lung cancer or malignant pleural mesothelioma. Previous research has shown that these patients are typically less physically … Continue reading Home-Based Rehab Helps Mesothelioma Patients Bounce Back After Chemotherapy 
Simple Blood Test Detects Mesothelioma Progression - Malignant mesothelioma patients may not need multiple CT scans to tell whether their cancer has progressed in the months after chemotherapy treatment. UK researchers say a simple blood test to check their levels of the protein mesothelin costs less, requires fewer hospital visits, and is 96 percent accurate in most mesothelioma patients. Measuring Mesothelioma Progression The study was conducted by scientists at the University … Continue reading Simple Blood Test Detects Mesothelioma Progression 
Mini-Tumors May Help Doctors Develop Personalized Mesothelioma Treatments - Doctors at Wake Forest University are using miniature lab-grown three dimensional tumors to test personalized mesothelioma treatments. The mini-tumors are known as organoids and are grown from biopsy tissue taken from patients diagnosed with mesothelioma. Researchers say they can serve as models to try out new mesothelioma therapies before using them on patients. “There is a need for model systems to help predict personalized responses … Continue reading Mini-Tumors May Help Doctors Develop Personalized Mesothelioma Treatments 
Clinical Trials Often the Best Option for Malignant Mesothelioma - Newly-diagnosed patients with malignant mesothelioma are forced to face a harsh reality early on in their cancer journey – there is no universally effective treatment for this aggressive cancer. In fact, as a highly resistant malignancy, mesothelioma is often unresponsive to even the “gold standard” treatment combination of pemetrexed (Alimta) and cisplatin. But that does not mean that mesothelioma patients do not have options. Clinical … Continue reading Clinical Trials Often the Best Option for Malignant Mesothelioma 
Mesothelioma Treatment May Be More Effective Without This Enzyme - An international team of researchers has published data they believe could dramatically boost the effectiveness of chemotherapy for malignant mesothelioma. Malignant mesothelioma is a highly lethal, asbestos-linked cancer. One of the reasons it is so difficult to cure is that it is resistant to all of the standard cancer drugs. Now, scientists with the University of New Mexico, the University of Kansas, and Semmelweis University … Continue reading Mesothelioma Treatment May Be More Effective Without This Enzyme 
Managing Taste and Smell Changes During Mesothelioma Treatment - If you are a mesothelioma patient dealing with changes in how you taste or smell your food, you are not alone. A new study of lung cancer patients in the same situation suggests that healthcare professionals could be doing more to help. Treatment-related changes in taste and smell are common among people with malignant mesothelioma and other types of cancer. Chemotherapy can change a person’s … Continue reading Managing Taste and Smell Changes During Mesothelioma Treatment 
“My Name is Paul Kraus and I Have Survived Mesothelioma for Over 20 Years.”
In 1997 I was diagnosed with mesothelioma. The doctors gave me just a few short months to live...
But here I am, 20 years later, alive and well.
I wrote a book explaining how I became the longest living mesothelioma survivor in the world.
Today, I'd like to give you a copy for free because I want more people to survive this disease.
All you have to do is click the button below now. You will receive the book within 72 hours.
I wish you good health.
Sincerely,
"It has been over four years now and I can honestly say I am doing great. I highly recommend this book because it is inspirational and educational."